These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 894287)

  • 21. Mass fragmentographic assay of homovanillic acid in brain tissue.
    Sjöquist B; Dailey J; Sedvall G; Anggård E
    J Neurochem; 1973 Mar; 20(3):729-33. PubMed ID: 4703787
    [No Abstract]   [Full Text] [Related]  

  • 22. A simple radioenzymatic method for determination of picogram amounts of 3,4-dihydroxyphenylacetic acid (DOPAC) in the rat brain.
    Argiolas A; Fadda F; Stefanini E; Gessa GL
    J Neurochem; 1977 Sep; 29(3):599-601. PubMed ID: 894314
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra.
    Waldmeier PC; Kam R; Stöcklin K
    Brain Res; 1978 Dec; 159(1):223-7. PubMed ID: 728796
    [No Abstract]   [Full Text] [Related]  

  • 24. Reserpine-like action of chlorpromazine on rabbit basal ganglia.
    Tagliamonte A; Tagliamonte P; Gessa GL
    J Neurochem; 1970 Jun; 17(6):733-8. PubMed ID: 5426652
    [No Abstract]   [Full Text] [Related]  

  • 25. Blockade of the central effects of d-amphetamine sulfate by amantadine hydrochloride.
    Menon MK; Clark WG; Fleming RM
    Eur J Pharmacol; 1973 Mar; 21(3):311-7. PubMed ID: 4708069
    [No Abstract]   [Full Text] [Related]  

  • 26. Decrease of homovanillic, dihydroxyphenylacetic acid and cyclic-adenosine-3',5'-monophosphate content in the rat caudate nucleus induced by the acute administration of an aminoacid mixture lacking tyrosine and phenylalanine.
    Biggio G; Porceddu ML; Gessa GL
    J Neurochem; 1976 Jun; 26(6):1253-5. PubMed ID: 180254
    [No Abstract]   [Full Text] [Related]  

  • 27. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic elevation of brain 3,4-dihydroxyphenylacetic acid concentration by methylphenidate and spiperone in control but not reserpine-pretreated rats.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1979 May; 31(5):339. PubMed ID: 37308
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of ethanol on the metabolism of regional brain dopamine.
    Fadda F; Argiolas A; Melis MR; Serra G; Congia S
    Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2559-63. PubMed ID: 7470303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of dopamine in the ventral tegmental area of rat.
    Fadda F; Melis MR; Argiolas A; Perra G
    Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1178-83. PubMed ID: 553533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A radioenzymatic assay for catecholamines and dihydroxyphenylacetic acid.
    Saller CF; Zigmond MJ
    Life Sci; 1978 Sep; 23(11):1117-30. PubMed ID: 30872
    [No Abstract]   [Full Text] [Related]  

  • 32. Simultaneous determination of serotonin, 5-hydroxindoleacetic acid, 3,4-dihydroxyphenylacetic acid and homovanillic acid by high performance liquid chromatography with electrochemical detection.
    Sperk G
    J Neurochem; 1982 Mar; 38(3):840-3. PubMed ID: 6173467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid concurrent automated fluorimetric assay of noradrenaline, dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 3-methoxytyramine in milligram amounts of nervous tissue after isolation on Sephadex G10.
    Westerink BH; Korf J
    J Neurochem; 1977 Oct; 29(4):697-706. PubMed ID: 591945
    [No Abstract]   [Full Text] [Related]  

  • 34. L-DOPA and reserpine: effects on evoked potentials in basal ganglia of freely moving rats.
    Dafny N; Gilman S
    Brain Res; 1973 Feb; 50(1):187-91. PubMed ID: 4690546
    [No Abstract]   [Full Text] [Related]  

  • 35. Simultaneous determination of catecholamines and unconjugated 3,4-dihydroxyphenylacetic acid in brain tissue by ion-pairing reverse-phase high-performance liquid chromatography with electrochemical detection.
    Mefford IN; Gilberg M; Barchas JD
    Anal Biochem; 1980 May; 104(2):469-72. PubMed ID: 7446972
    [No Abstract]   [Full Text] [Related]  

  • 36. Biphasic effects of m-chlorophenyl-piperazine on 3,4-dihydroxyphenylacetic acid concentration in rat brain.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):551-4. PubMed ID: 897345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catalepsy, DOPAC, and acetylcholine during chronic fluphenazine administration.
    Bowers MB; Bowers SM
    Commun Psychopharmacol; 1978; 2(6):533-7. PubMed ID: 570903
    [No Abstract]   [Full Text] [Related]  

  • 38. Voltammetry in the striatum of chronic freely moving rats: detection of catechols and ascorbic acid.
    Gonon F; Buda M; Cespuglio R; Jouvet M; Pujol JF
    Brain Res; 1981 Oct; 223(1):69-80. PubMed ID: 7284811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid.
    Guldberg HC; Yates CM
    Br J Pharmacol Chemother; 1968 Jul; 33(3):457-71. PubMed ID: 5728318
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of drugs on regional brain concentrations of dopamine and dihydroxyphenylacetic acid.
    Umezu K; Moore KE
    J Pharmacol Exp Ther; 1979 Jan; 208(1):49-56. PubMed ID: 32385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.